What does HENNGE do?
HENNGE sells cloud-security software to enterprises that run daily work on cloud applications. Its core product, HENNGE One, helps IT teams control who can access company cloud services and protect business email. Customers pay recurring subscription fees, and the product becomes sticky once login rules, identity controls, and email-security policies sit inside daily IT operations. The investor debate is whether HENNGE can keep compounding through more seats and a higher Pro-tier mix while marketing spend, module-level disclosure, and margin discipline remain under control. The key checks are ARR growth, customer and user expansion, Pro-plan adoption, and whether the FY26 investment step-up converts into visible recurring revenue.
What has driven the stock over the past two years?
The share rose from around ¥1,000 in May 2024 to ¥1,899 in August 2025, then fell more than 50% to ¥913 by March 2026. The rally reflected stronger recurring-revenue evidence. The reversal started with the November 2025 FY26 plan and was reinforced by the next two ARR prints, which pointed to a slower FY26 ARR trajectory and heavier growth investment.
01 · THE RALLY HENNGE One manages cloud login access and protects business email for enterprise IT teams. Enterprise customers pay recurring subscription fees, and the service becomes harder to replace once login rules and security policies are built into daily operations. Revenue then compounds as customer logos increase, as users inside each account expand, and as accounts move from Basic to the higher-priced Pro bundle with fuller identity, data-loss-prevention, and cybersecurity functions. Through FY24 results and the FY25 quarterly prints, the evidence was consistent: revenue growth stayed around the high-20s to 30% zone, ARR moved through ¥10bn, customer logos approached 3,500, gross margin improved from 84.8% to 86.4%, and monthly gross-revenue churn fell to 0.26%. The market read this as proof that recurring growth was durable, so the stock rose from around ¥1,000 in May 2024 to ¥1,899 on August 14, 2025, with peak pricing assuming that pace could continue.
02 · THE REVERSAL The reversal started with the November 2025 FY25 results package. Reported FY25 performance itself was strong — revenue +30.6%, operating profit +71.4%, and ARR above ¥10.4bn — but the FY26 setup changed expectations. Management guided FY26 revenue growth to +17.5% and operating margin to 16.0% versus 16.4% in FY25, while planning a heavier branding and marketing push for adjacent launches: HENNGE Endpoint & Managed Security (launched March 2026), a domain-protection module (planned for autumn 2026), and the US joint-venture build-out. The next two prints then confirmed slower ARR momentum: +15.5% YoY in Q1 FY26 and +14.7% in Q2 FY26. Management also noted in Q2 that average users per contracted company fell because new wins skewed smaller, and that some larger customers chose single-feature plans (Identity-only or DLP-only) instead of the full Pro bundle. That combination pressured both growth quality and multiple confidence. The share price declined for six months and reached ¥913 on March 13, 2026, a drawdown of just over 50% from the August peak.
03 · WHERE WE STAND NOW After the November plan, management added a capital-allocation signal but it did not stop the de-rating. On November 21, 2025, the board authorized a repurchase of up to 700,000 shares (just over 2% of shares outstanding) with a ¥1.19bn cap. Execution ran from late November to December 22, with all 700,000 shares bought for ¥909.988M at roughly ¥1,300 per share on average. Management described the program as both dilution offset (for restricted stock, stock options, and possible share-based M&A) and broader capital-allocation discipline. Even so, the stock kept falling into the March trough, then recovered only partway to ¥1,016 at the May 12, 2026 close. The core operating profile still screens strong: ROCE on averaged capital employed around 48%, gross margin around 86.8% and still improving, and free-cash-flow yield around 8% at the current share price. The unresolved question is valuation, not business viability: at ¥1,016 the stock trades near 12.5x forward EV/EBIT, below the August 2025 peak multiple of roughly 22x. The next four quarters should decide whether the market returns to a growth-compounding view or keeps a lower multiple for slower ARR and heavier investment.
What are investors debating now?
Three questions from recent quarterly disclosures and IR Q&A drive the current multiple debate. Each has a clear check investors can verify over the next few quarters.
What could change over the next twelve months?
These are disclosure and capital-policy levers already visible in filings. Any one of them could change how investors frame quality and valuation, even before earnings move.
What has to be true for the stock to work from here?
JII uses three internally consistent scenarios across the next four quarters. These are JII analytical cases, not company guidance and not predictions.
- Q4 FY26 ARR growth lands at +12% YoY or below.
- FY26 OPM revises to ≤14% on branding spend that does not convert.
- No ARR-by-module disclosure; no second buyback at FY26 results.
- Pro mix stalls at 21–22% (vs the ≥25% needed for FY29 ARR ¥20bn math).
The bear floor of ¥800 sits above the JP private-buyer 7–10x EV/EBIT range, so the floor is multiple-driven rather than take-private-driven.
- ARR growth holds in the +14–18% range through FY26.
- FY26 OPM closes at 15–17% (within guidance).
- One of the three CATALYST levers lands by Q4 FY26 (most likely module-disclosure, given the new-product cadence).
- Capital-allocation language at FY26 results acknowledges either a second buyback or a sustainable cash-return framework.
- Q3/Q4 ARR re-accelerates to +20% YoY on Endpoint + domain-protection cross-sell.
- Pro mix advances to ≥25% with disclosed absolute ARR.
- ARR-by-module disclosure begins.
- Formal capital-allocation framework articulated (e.g. ≥X% of FCF returned annually with hurdle-rate buyback gate).
The bull peak of ¥1,700 stays below the Aug 2025 high of ¥1,899 — the framework does not embed a return to the peak ~22x forward EV/EBIT multiple. That requires both ARR re-acceleration AND a successful US JV pivot, which is two-stage optionality outside this four-quarter scenario.
This is not investment advice.
Japan Investor Interface Co., Ltd. ("JII") is an investor-relations (IR) consultancy. JII is not a registered investment advisor, financial advisor, broker-dealer, or securities firm in any jurisdiction. JII is not registered as a Financial Instruments Business Operator (金融商品取引業者) under Japan's Financial Instruments and Exchange Act. JII does not have a 投資助言・代理業 registration and does not provide investment advice or solicit the purchase, sale, or holding of any security.
JII Compounders is an editorial publication. Each profile is an analytical study of how publicly disclosed information about a Japanese listed company has been received by the market. It is intended for educational and research purposes for IR professionals, finance students, journalists, and other readers interested in corporate disclosure practice. Nothing in this publication constitutes a recommendation, opinion, suggestion, or solicitation to buy, sell, or hold any security, derivative, or other financial instrument. Price targets, scenario ranges, multiples, and comparable-company references are illustrative of analytical method only and must not be interpreted as JII's investment opinion. JII does not have an investment opinion on any security discussed.
No reliance. The information presented may be incomplete, out of date, or incorrect. Forward-looking statements are inherently uncertain. Past price performance does not indicate future results. Estimates and scenario figures are not predictions and may not be achieved. JII makes no representation or warranty, express or implied, regarding the accuracy, completeness, timeliness, or reliability of any information in this publication.
No fiduciary or advisory relationship. Reading this publication does not create any advisory, fiduciary, or professional relationship between you and JII. Before making any investment, tax, accounting, legal, or other decision, you should consult qualified, licensed advisors in your jurisdiction and conduct your own independent due diligence based on primary disclosures issued by the company concerned.
Conflicts & positions. JII may provide paid IR diagnostic, translation, or interpretation services to Japanese listed companies, including companies discussed in this publication. JII does not trade in or hold positions in the securities of companies profiled. Where a JII engagement exists with a profiled company, that fact will be disclosed at the top of the profile.
Trademarks & data. Company names, logos, tickers, and product names referenced are the property of their respective owners. Share-price data is licensed from third-party providers. TradingView is a trademark of TradingView, Inc. All rights reserved.
本資料は、日本の金融商品取引法に基づく投資助言・代理業ではなく、特定の有価証券の売買その他の取引の勧誘・推奨を目的とするものではありません。本資料は教育・研究を目的とした分析記事であり、JII（株式会社ジャパン・インベスター・インターフェース）は、本資料の内容に基づく投資判断について一切の責任を負いません。投資の判断はご自身の責任と独立した調査に基づいて行ってください。